Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node...

Area of Science:

• Oncology
• Surgical Pathology
• Melanoma Research

Background:

• Sentinel lymph node (SLN) positivity is a significant indicator of poor prognosis in melanoma patients.
• Accurate prognostic markers are crucial for guiding treatment decisions in melanoma management.

Purpose of the Study:

• To validate the prognostic significance of sentinel lymph node biopsy (SLNB) in melanoma.
• To correlate micromorphometric features of SLN metastases with patient prognosis.
• To assess the relationship between SLN metastasis characteristics and the likelihood of positive completion lymph node dissection (CLND).

Main Methods:

• A retrospective analysis of 455 primary melanoma cases undergoing SLNB.
• Detailed registration of micromorphometric features for SLN metastases in positive cases.
• Statistical analysis including Kaplan-Meier survival curves, log-rank tests, Cox regression, and logistic regression models.

Main Results:

• SLNB positivity was identified in 98 cases, correlating with significantly shorter survival.
• Extracapsular invasion emerged as an independent prognostic factor for disease-free survival.
• Tumor burden, specifically the maximum diameter of the largest metastasis, predicted disease-specific survival.
• The lowest diameter of the largest metastasis was a novel predictor of positive CLND status.

Conclusions:

• SLNB is a powerful prognostic tool in melanoma, confirming previous findings.
• Tumor burden in the SLN, particularly metastasis size, is directly related to clinical outcomes.
• The lowest diameter of the largest metastasis represents a new, potentially valuable predictor for CLND status in melanoma patients.